• SHARE

As nations race to develop treatments and vaccines for COVID-19, Japan has become a victim of its own success as slowing new infections have led to a shortage of patients to enroll in clinical trials.

Clinical trials are underway for more than a dozen potential vaccines, including at least six in China, but Japan’s first human trials are expected to start next month.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)